Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BetterLife Pharma Inc BETRF


Primary Symbol: C.BETR

BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be... see more

CSE:BETR - Post Discussion

BetterLife Pharma Inc > Why is she tanking today?
View:
Post by SilverSpewn on Jan 05, 2021 3:48pm

Why is she tanking today?

Anyone have any insights?
Comment by BBAccount001 on Jan 05, 2021 4:05pm
Old shareholders from the CBD days getting out. I took the opportunity to accumulate some more.
Comment by elgin1 on Jan 05, 2021 6:04pm
Same here . Anything under $2 is good buy imo.
Comment by goldmike on Jan 11, 2021 4:53pm
Not for to long.. bargain prices under $2 if comps trading at $B+
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities